lobbying_activities: 1659398

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1659398	0ae8782a-e4e9-4bc3-bcdd-ab34c71ec19d	Q1	WILLIAMS AND JENSEN, PLLC	41454	GENENTECH INC	2015	first_quarter	HCR	21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); Potential pharmaceutical provisions in House Budget Resolution (H. Con. Res. 27) and Senate Budget Resolution (S. Con. Res. 11 ); Possible drug provisions in H.R. 2, the Medicare Access and CHIP Reauthorization Act; issues concerning clinical trials; issues concerning drug compounding; Implementation of Patient Protection and Affordable Care Act; Drug pricing under 340B program.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2015-04-13T14:38:38.767000-04:00